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The marine toxin domoic acid (DA),
produced by the cosmopolitan diatom species
Pseudonitzchia, affects numerous organisms in
the wild through trophic transfer, including
sea birds, manatees, dolphins, and sea lions,
as well as humans (Gulland et al. 2002;
Lefebvre et al. 1999; Perl et al. 1990; Scholin
et al. 2000; Work et al. 1993). DA is an
excitotoxin that binds to kainate subtypes of
ionotropic glutamate receptors as a high afﬁn-
ity partial agonist that prevents normal chan-
nel inactivation, leading to depolarization and
release of glutamate. This then activates
NMDA (N-methyl-D-aspartate) ionotropic
receptors to excite seizure-prone circuitry in
the limbic region of the brain (Ramsdell
2007). The behavioral effects of DA expo-
sure, such as scratching, ataxia, tremors, and
seizures, are well documented in various adult
experimental organisms including mice, rats,
and cynomolgus monkeys (Iverson et al.
1989; Tasker et al. 1991; Tryphonas et al.
1990a, 1990b). These same symptoms have
been documented in stranded California sea
lions exposed to DA (Gulland et al. 2002).
Prolonged neuronal excitation caused by
exposure to DA can also cause damage to the
hippocampus (Peng et al. 1994), which has
been linked to learning (Clayton et al. 1999)
and memory deﬁcits in experimental animals
as well as humans and marine mammals
(Brodie et al. 2006; Petrie et al. 1992;
Scholin et al. 2000; Sutherland et al. 1990;
Teitelbaum et al. 1990).
An increasing number of studies have
examined the developmental effects of prenatal
DA exposure, although it is still relatively
poorly understood. Already researchers have
determined that exposure to nonsymptomatic
levels of DA in utero can cause neurologic and
behavioral effects that persist even into adult-
hood. When mice were exposed prenatally,
severe hippocampal degradation was observed
14 days after birth (Dakshinamurti et al.
1993). Neonatal rats were shown to be more
susceptible to DA exposure than adults, most
likely caused by insufﬁcient clearance of DA
due to immature renal function (Doucette
et al. 2000; Xi et al. 1997). Memory loss and
learning deficits persist in embryonic rats
exposed to DA in midgestation (Levin et al.
2005), but animals are less affected when
exposed in late gestation (Levin et al. 2006).
These previous studies clearly demonstrate
that nonsymptomatic doses of DA can cause
neurologic and developmental damage when
organisms are exposed prenatally. Studies
have also addressed how the toxin crosses
from plasma to brain tissue through the
blood–brain barrier (BBB), presumably
through the capillary endothelium. Johansson
et al. (2006) used tracers similar in size and
permeability to DA and determined that the
tight junctions on capillary endothelial cells,
generally assumed to be a major factor for the
impermeability of small polar molecules into
the brain, are in place and operating very
early in development.
The importance of understanding how
DA partitions between the exposed mother
and the developing fetuses during an in utero
exposure experiment can help better deter-
mine how DA affects naturally exposed
humans and animals and the reproductive
health impacts thereof. No conﬁrmed cases of
DA intoxication in humans have been
reported since the 1987 human exposure in
Canada (Perl et al. 1990); however, subse-
quent identiﬁcation of DA in shellﬁsh in the
Pacific Northwest has lead to concern of
potential human intoxications, especially in
communities that are subsistent on local shell-
fish resources. DA intoxication has been
shown to be responsible for 9% of all sea lion
strandings on the West Coast (Greig et al.
2005) and is one cause of reproductive failure
seen in California sea lions. In 1998 and
2002, 209 combined strandings of pregnant
California sea lions were attributed to DA tox-
icity, with transfer of DA from the mothers to
the young in utero; all 209 animals sub-
sequently showed reproductive failure in the
form of spontaneous abortion, premature
birth, or the mortality of the female (Brodie
et al. 2006). These observances indicate the
necessity of good biomonitoring capabilities,
as well as the need to understand the mecha-
nisms and impacts of toxins on marine mam-
mal populations, especially when reproductive
processes are susceptible.
To better determine how much DA is
transferred from an exposed mother to its
young in utero, we measured DA concentra-
tions in maternal plasma and brain tissue,
amniotic fluid, and fetal brain tissue. We
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BACKGROUND AND OBJECTIVES: Prenatal exposure to asymptomatic doses of domoic acid (DA)
causes learning and memory deﬁcits later in life; therefore, we sought to measure distribution of
DA in maternal plasma and brain, prenatal brain, and amniotic ﬂuid 1 hr after exposure, a time
frame that normally encompasses acute seizure behavior.
METHODS: Pregnant rats were given a single intravenous dose of DA (0.6 or 1.6 mg/kg body weight)
at either gestational day (GD) 13 or GD20, which correspond to the beginning of rat embryo neuro-
genesis and the last day of gestation, respectively. Using a direct ELISA, dose-dependent levels of DA
were detected in each sample matrix tested.
RESULTS: An average of 6.6 and 14 ng DA/g brain tissue was found in GD13 and GD20 prenatal
rats, respectively. Brain concentrations of DA in the GD13 prenates were identical to amniotic ﬂuid
levels, consistent with no restriction for DA to enter the GD13 prenatal brain. At GD20 the prenatal
brain contained half the concentration of DA in the amniotic ﬂuid, and was approximately half that
found in the brain of the dams. After 1 hr, fetal brain and amniotic ﬂuid contained between 1 and
5% of DA found in the maternal circulation. The amniotic ﬂuid levels of DA in this study were also
within the same range measured in stranded California sea lions that showed reproductive failure.
CONCLUSIONS: DA crosses the placenta, enters brain tissue of prenates, and accumulates in the
amniotic ﬂuid. Amniotic ﬂuid appears to be a useful ﬂuid to monitor DA exposure.
KEY WORDS: California sea lion, domoic acid, prenatal exposure, rats. Environ Health Perspect
115:1743–1746 (2007). doi:10.1289/ehp.10446 available via http://dx.doi.org/ [Online
19 September 2007]anticipate using this information to understand
the dose response to DA exposure, the parti-
tioning of DA in tissues, and the usefulness of
amniotic fluid as a marker of fetal exposure.
Identiﬁcation of physiologically relevant con-
centrations of DA in amniotic ﬂuid could be
used to score potential toxicity effects later in
life, as well as to understand the magnitude to
which it may contribute to the observed pre-
mature parturition seen in the West Coast.
This will also aid in treatment of those animals
that are determined to have been exposed.
Methods
Rat exposure. All animal exposures were per-
formed by Argus Research (Horsham, PA), a
division of Charles River Laboratories, Inc.
(Boston, MA). Experiments were carried out
according to the Guide for the Care and Use of
Laboratory Animals (Institute of Laboratory
Animal Resources 1996), and animals were
treated humanely and with regard to allevia-
tion of suffering. Thirty-four female rats
(281–387 g) and their respective litters were
provided by Charles River Laboratories, Inc.,
and exposed dams were divided into six treat-
ment groups (Table 1). Our sublethal doses
were chosen based on previously used doses
that showed hippocampal damage during
fetal development (Dakshinamurti et al.
1993; Levin et al. 2005); initial range-ﬁnding
exposures showed that 0.6 mg/kg body
weight (bw) was nonsymptomatic to the dam,
and 1.6 mg/kg caused minimal observational
effects. Groups I, II, and III were injected
intravenously (iv) on gestational day (GD) 13
and groups IV–VI were injected (iv) on
GD20. Groups II and V were administered a
nonlethal dose of 0.6 mg/kg (0.1 mg/mL) DA
(Sigma-Aldrich, St. Louis, MO) in phosphate-
buffered saline (PBS); groups III and VI were
injected (iv) with 1.6 mg/kg DA; and groups
I and IV were injected with an equal volume
of control vehicle (PBS) only. 
All rats were sacrificed at 1 hr post-
exposure. Blood was collected from dams,
transferred into dipotassium EDTA-coated
tubes, and centrifuged to collect the plasma
fraction, which was then frozen (< –20°C)
until shipment for analysis. Amniotic fluid
samples were also collected from each dam,
pooled by litter, and frozen (< –20°C) until
shipment for analysis. Fetuses were removed
from the uterus, and whole brain tissues were
removed, individually snap frozen in liquid
nitrogen, and maintained frozen (< –68°C)
until shipment for analysis. Maternal rat
brains were removed, and three brain regions
were dissected out (frontal cortex, hippocam-
pus, and hypothalamus) from this experiment
at 1 hr postexposure. In a second experiment,
the same maternal brain sections were col-
lected from rats dosed at 1.6 mg/kg bw 2–4 hr
after exposure; however, the brains were vascu-
larly perfused with saline before dissection.
Tissue extraction. While still frozen, each
brain or brain section was weighed, minced,
and suspended in an equal volume of
10 mM PBS with 10% methanol and 0.05%
Tween 20 (sample/standard buffer). Tissues
were extracted by the addition of three times
homogenate volume of 50% methanol and
homogenized with a hand-held Teflon
homogenizer in a 0.05-mL microcentrifuge
tube (Kimble-Kontes, Vineland, NJ). Extracts
were centrifuged at 3,000 × g (IEC Centra
CL2 Benchtop centrifuge; Thermo Electron
Corporation, Waltham, MA) and the super-
natant removed for further analysis. All sam-
ples and sample extracts were diluted in
sample/standard buffer, with plasma diluted
5,000- to 10,000-fold, amniotic ﬂuid diluted
500-fold, and brain tissue diluted 40- or
100-fold in order to fall in the working range
of the assay.
ASP direct cELISA kit. ASP (amnesic
shellfish poison) direct cELISA kits from
Biosense Laboratories (Bergen, Norway) were
used for the analysis of all plasma, amniotic
ﬂuid, and brain tissue samples. This kit uses a
polyclonal ovine anti-DA antibody conjugated
to horseradish peroxidase (HRP), to which
free DA in samples or standards compete with
DA-conjugated proteins coated on the plate
well surface (Garthwaite et al. 1998). Samples
were incubated with the antibodies, washed
with PBS with 0.05% Tween 20, and then
treated with TMB (3,3´,5,5´-tetramethyl-
benzidine), which reacts with the HRP
enzyme to form a blue end product. Addition
of 0.3 M sulfuric acid turned the blue to yel-
low, and the plate was read on a NovoStar
plate reader (BMG Labtechnologies, Durham,
NC) at 450 nm. Analyses of DA concentra-
tions in the standard curve and samples were
performed using ELISA data processing soft-
ware provided by Biosense Laboratories.
Additional analyses were done using Prism 4.0
(GraphPad, San Diego, CA).
Results
GD13 animals. The DA-exposed dams had
high plasma levels of DA, with the low-dose
group (0.6 mg/kg) having an average of 166 ng
DA/mL and the high-dose group (1.6 mg/kg)
an average of 716 ng/mL 1 hr postexposure
(Figure 1A). The limit of quantification
(LOQ) for plasma samples was < 1 ng/mL. All
prenates at both doses had detectable levels of
DA in their brain tissue and amniotic fluid.
Brain tissues from the 0.6-mg/kg group (n =5 )
averaged 7.5 ng DA/g tissue equivalents (TE),
and the 1.6 mg/kg group (n = 10) had an aver-
age of 16.9 ng DA/g TE (Figure 1B). No
matrix effects were seen in the 1:40 dilution of
brain tissue. The LOQ for brain tissue at the
1:40 dilution was 0.4 ng/mL, or 2.8 ng DA/g
TE. Amniotic fluid concentrations averaged
8.7 and 21.0 ng/mL for the low- and high-
dose groups, respectively (Figure 1B). The
LOQ for amniotic ﬂuid was < 1 ng/mL.
GD20 animals. The plasma levels of DA
in the exposed mothers at the later gesta-
tional date had the highest concentrations,
with the low-dose group having an average of
654.7 ng DA/mL and the high-dose group
an average of 1,600 ng/mL 1 hr postexposure
(Figure 2A). Again, all prenates at both doses
had detectable levels of DA in their brain tis-
sue; however, the levels were similar to those
in the GD13 group. Prenate brain tissues in
the 0.6-mg/kg group (n = 10) averaged 5.3 ng
DA/g TE; the 1.6-mg/kg group (n = 10) had
an average of 11.4 ng DA/g TE (Figure 2B).
Amniotic ﬂuid concentrations averaged 11.1
and 31.2 ng/mL for the low- and high-dose
groups, respectively (Figure 2B). The LOQ
values were the same as for the GD13 animals
(noted above).
Maternal brain DA concentrations. The
brains of the dams in the 1.6-mg/kg group
contained averages of 18, 29, and 24 ng
DA/g TE for the frontal cortex, hypothala-
mus, and hippocampus, respectively. The
concentration of DA in brain tissue was not
reduced by rinsing blood from the vascula-
ture by saline perfusion (Table 2). The brains
of dams in the low-dose group showed lower
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Table 1. Designation of groups based on DA expo-
sure dose and gestational time point.
GD13 GD20
(n = 10) (n = 10)
Dose (mg/kg bw) 0 0.6a 1.6 0 0.6 1.6
Group I II III IV V VI
an = 5
Figure 1. Toxin distribution in tissues of rats exposed to DA on GD13. (A) Concentration of DA in maternal
blood plasma (n = 5). (B) Concentration of DA in fetal brain tissue and amniotic fluid (n = 10). Error bars
indicate SE. All controls were below the limit of detection. 
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and hippocampus, respectively).
Discussion
The concern regarding the transfer of toxins or
other harmful substances from mother to
young and the possible in utero effects extends
beyond humans alone, especially when marine
mammals are known to be susceptible to DA
intoxication events with ramiﬁcations for their
offspring. In the present study, using rats as a
model, we have shown that DA not only
crosses the placenta but also can reach the
brain tissue of prenates and accumulate in the
amniotic ﬂuid. Here we focus on these concen-
trations of DA in the context of being toxico-
logically relevant to fetal development not only
to our experimental animals but also poten-
tially to animals naturally exposed to DA, such
as the California sea lion.
The DA doses used in this study were
both nonsymptomatic to the pregnant rats;
however, previous studies using similar doses
have been shown to cause neurologic and
behavioral effects later in life for the pre-
nates. Prenatal mice exposed in utero to
0.6 mg/kg DA on GD13 showed no patho-
logical effects at birth; however, at 14 days
of age, hippocampal damage was evident
with a decreased seizure threshold to subse-
quent DA exposure (Dakshinamurti et al.
1993). Levin et al. (2005) found several
latent neurobehavioral effects at similar DA
doses (0.6 and 1.2 mg/kg) given to rats on
GD13. Prenatal rats exposed at this develop-
mental time point had no observable toxicity
effects, but they showed decreased locomotor
activity, a diminished sex-ratio differential in
spatial discrimination learning, and a dose-
dependent increase in the amnesic response to
scopolamine when tested later in adolescent
and early adult life (Levin et al. 2005). When
prenatal rats were exposed on postnatal days 1
and 2 (total gestation is 21 days) and under-
went the same testing regime as the GD13
rats, Levin et al. (2006) found fewer impair-
ments to neurobehavioral function, with
hypoactivity being the only signiﬁcant effect
observed. This suggests that rats are more sen-
sitive to delayed DA effects with exposure on
GD13 and that DA doses which are non-
symptomatic to the mother are sufficient to
cause developmental effects in their young
when exposed at a susceptible gestational time
point such as GD13.
The comparison of DA partitioning in the
maternal and prenatal brain tissues showed
that the concentrations measured are dose
dependent and relatively similar to each other.
This suggests that the brains of the prenates are
exposed to roughly the same DA dose as their
mothers despite the protective barrier of the
placenta and/or the BBB. DA initially enters
the brain of adults, presumably at the level of
capillaries, with a transfer constant of 12 µg/kg
for a low-level exposure to radiotracer DA
(Preston and Hynie 1991). Kim et al. (1998)
modeled partitioning of DA in various brain
regions of the rat using the data of Preston and
Hynie (1991) and predicted that 70 pg/g TE
would accumulate after 1 hr in the frontal cor-
tex at the DA radiolabel tracer concentration of
7 µg/kg. This converts to 16 ng/g TE for a
1.6-mg/kg dose used in the present study. This
theoretical value is very close to our measured
value of 18 ng/g TE in the maternal frontal
cortex. Because the maternal blood concentra-
tion of DA was very high at this dose and time,
we were concerned that blood contamination
elevated our values, but our comparison to per-
fused brain sections did not reduce the toxin
level in the brain.
The concentration of DA in the brain of
the prenates was approximately half of the
average maternal brain concentration at
GD20, and roughly equal at GD13. This
indicates that upon in utero exposure, the pre-
nates and mothers are exposed to similar
brain DA concentrations at a level previously
shown to activate ionotropic glutamate recep-
tors. Xi and Ramsdell (1996) showed that
16 ng/ml DA is sufﬁcient to induce calcium
entry into hippocampal pyramidal cells in
adults, and it is evident from other studies
(Dakshinamurti et al. 1993; Levin et al.
2005) that even the low-dose exposure of
0.6 mg/kg on GD13 is sufficient to have an
adverse effect on neurodevelopment. The
effective brain concentrations for DA are likely
higher (approximately 7-fold) than the TEs
would suggest because of the low extracellular
water space in the brain. Hence, the brain DA
concentrations are likely to be several-fold
higher than threshold values in cultures of
neurons.
We found the tissue concentrations of DA
in the prenatal brain to be similar to the con-
centrations of DA in the amniotic ﬂuid. Our
findings parallel those of Johansson et al.
(2006) in their investigation of the permeabil-
ity of a small, water-soluble marker similar in
size to DA (14C-sucrose; molecular weight of
DA is 311) in GD13 and GD18 prenates.
Their results showed the cerebrospinal fluid
(CSF)/plasma marker concentration ratios to
be 100% on GD13, with a decrease to 39% on
GD20 (Johansson et al. 2006). Although early
studies indicated that tight junctions between
the brain and endothelial cells of the blood
capillaries form the functional BBB in adults
(Brightman and Reese 1969; Reese and
Karnovsky 1967), subsequent studies have
indicated an alternative mechanism of entry of
small polar molecules into the brain of prenatal
animals (Johansson et al. 2006). Tight junc-
tions of brain–blood capillaries are fully func-
tional at least as early as GD15, whereas the
barrier between the brain and CSF develops
later. With consideration to these studies, our
results indicate that the DA enters the GD13
brain without restriction and, even though
capillary tight junctions are fully functional
shortly afterward, DA continues to enter the
brain later in prenatal development with
approximately a 50% restriction.
DA accumulates within 1 hr in the amni-
otic ﬂuid in GD13 and GD20 rats, indicating
that it readily crosses the placental barrier and
is excreted by the prenates. The DA levels we
measured in this experiment (8–21 ng/mL) fell
within the same range of values (4–34 ng/mL)
measured by Brodie et al. (2006) in stranded
pregnant sea lions. The amniotic fluid and
brain DA levels may be in equilibrium earlier
during in utero development, because fetal skin
is highly permeable to polar substances as it is
not keratinized until later in gestation.
Additionally, the primary dermal barrier,
which results from the deposition of lipids into
the zona corneum, does not become functional
in rats until the glucocorticoid surge just before
birth (Aszterbaum et al. 1993). Hence, DA in
amniotic fluid likely penetrates the skin of
earlier-gestation prenates readily.
Although elimination rates for DA from
amniotic ﬂuid remain to be conducted, analysis
Maternal–fetal transfer of domoic acid
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Table 2. Comparison of DA (mean ng DA/g TE) in
maternal brain sections from pregnant rats exposed
to DA at 1.6 mg/kg bw.
Perfused Nonperfused
Brain section (n = 4) (n = 2)
Frontal cortex 20.26 18.05
Hypothalmus 44.01 29.31
Hippocampus 31.69 24.20
Figure 2. Toxin distribution in tissues of rats exposed to DA on GD20. (A) Concentration of DA in maternal
blood plasma (n = 5). (B) Concentration of DA in fetal brain tissue and amniotic fluid (n = 10). Error bars
indicate SE. All controls were below the limit of detection.
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elimination rates suggest that DA will not
eliminate readily from the amniotic fluid
(Alnouti et al. 2004). Poor elimination of DA
from amniotic ﬂuid is also consistent with the
finding of DA in the amniotic fluid of
California sea lions. DA found in the amniotic
ﬂuid of one animal was detected 8 days after
the mother stranded (Brodie et al. 2006); this
concentration is comparable to our experimen-
tal rat values after only a 1-hr exposure. This
suggests that the recirculation of amniotic ﬂuid
acts as a sink for DA and continues to expose
the fetus long after the DA has been cleared by
the mother. The sea lion fetus also had compa-
rable DA levels in gastric fluid and amniotic
fluid, which suggests that these animals also
had the potential of in utero oral exposure to
DA (Brodie et al. 2006).
The GD13 developmental stage seems to
be a point of vulnerability for developmental
toxicity to DA; however, the potential of con-
tinued absorption of DA from the amniotic
ﬂuid by dermal exposure may place the tim-
ing of DA action on neurodevelopment
somewhat later. GD13 is a critical develop-
mental point in the mouse, as it is the begin-
ning of neurogenesis of the hippocampus
(Angevine 1965; Haubensak et al. 2004), and
the rat reaches this point a day or two later
(Bayer 1980). Exposure during this stage
might interfere with the clonal expansion
and/or migration of neuroprogenitor cells. A
toxic effect of DA on regional brain develop-
ment is supported by histochemical findings
that the hippocampus does not form properly
later in postnatal life of GD13 prenates
exposed to DA (Dakshinamurti et al. 1993).
GD20 approaches the end of neuroprolifera-
tion and migration of cells in the amnion
horn of the hippocampus, and fewer behav-
ioral effects are observed in animals exposed
to DA the ﬁrst 2 days after birth (Levin et al.
2006). Hence, sustained in utero exposure via
amniotic fluid suggests that the window for
DA toxicity for brain development still needs
to be narrowed between GD13 and GD20.
The present study is the ﬁrst experimental
determination of DA in biological ﬂuids and
brain tissue of pregnant rats and their fetuses.
Amniotic ﬂuid appears to be a promising indi-
cator of previous DA exposure in stranded
pregnant sea lions, especially because it seems
to be retained at measurable DA levels even
after DA has cleared from maternal plasma.
Our study showed similar measurable amounts
to those found in the wild. We report toxico-
logically relevant levels of DA in the brain of
developing fetuses, although the exact trans-
port mechanisms and the kinetics of DA trans-
port across the either the BBB or CSF–blood
barrier are still undetermined. In light of the
results from environmental exposures of
California sea lions and associated prenatal
deaths, identiﬁcation of in utero effect levels for
DA toxicity will be beneﬁcial to future health
assessment.
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